Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Stephen Schey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The management of Castleman disease
the British Society for Haematology (BSH) Committee, Nov 2021, In: British Journal of Haematology. 195, 3, p. 328-337 10 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access9 Citations (Scopus) -
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
the Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group, Dec 2020, In: American Journal of Hematology. 95, 12, p. 1553-1561 9 p.Research output: Contribution to journal › Article › peer-review
23 Citations (Scopus) -
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
OPTIMISMM trial investigators, 1 Jun 2019, In: The Lancet Oncology. 20, 6, p. 781-794 14 p.Research output: Contribution to journal › Article › peer-review
282 Citations (Scopus) -
Risk of relapse of multiple myeloma following kidney transplantation
Shah, S., Ibrahim, M., Delaney, M., Schey, S., Bygrave, C., Streetly, M. & Benjamin, R., Apr 2019, In: Clinical Kidney Journal. 12, 2, p. 216-223 8 p., sfy137.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus) -
Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: A prospective, multi-centre longitudinal study
Ramsenthaler, C., Gao, W., Siegert, R. J., Edmonds, P. M., Schey, S. A. & Higginson, I. J., 1 May 2019, In: Palliative Medicine. 33, 5, p. 541-551 11 p.Research output: Contribution to journal › Article › peer-review
31 Citations (Scopus)
Projects
- 10 Finished
-
Targeting osteoclasts podosomes in multiple myeloma
Calle, Y. (Primary Investigator) & Schey, S. (Co-Investigator)
1/02/2010 → 31/01/2013
Project: Research
-
Quality of life in patients with chronic haematological malignancies, during treatment into survivorship and/or relapse
Edmonds, P. (Primary Investigator), Higginson, I. (Primary Investigator) & Schey, S. (Co-Investigator)
KCH King's College Hospital NHS Foundation Trust
1/01/2010 → 31/12/2011
Project: Research
-
Developing a person-orientated schedule for use in routine care to measure quality of life among people affected by myeloma (the MyQoL)
Higginson, I. (Primary Investigator), Edmonds, P. (Co-Investigator), Schey, S. (Co-Investigator) & Siegert, R. (Co-Investigator)
1/10/2009 → 31/10/2013
Project: Research
-
Immune therapy of Leukaemia and multiple myeloma
Farzaneh, F. (Primary Investigator) & Schey, S. (Co-Investigator)
1/10/2009 → 30/09/2011
Project: Research
-
Osteoclast activity as a target for radionuclide and therapy in multiple myeloma and other osseous tumours.
Blower, P. (Primary Investigator), Mullen, G. (Co-Investigator) & Schey, S. (Co-Investigator)
1/10/2008 → 30/09/2012
Project: Research